174 related articles for article (PubMed ID: 12944549)
1. Expression of smooth muscle markers in so called malignant fibrous histiocytomas.
Hasegawa T; Hasegawa F; Hirose T; Sano T; Matsuno Y
J Clin Pathol; 2003 Sep; 56(9):666-71. PubMed ID: 12944549
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s.
Schürch W; Bégin LR; Seemayer TA; Lagacé R; Boivin JC; Lamoureux C; Bluteau P; Piché J; Gabbiani G
Am J Surg Pathol; 1996 Feb; 20(2):131-47. PubMed ID: 8554102
[TBL] [Abstract][Full Text] [Related]
3. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
[TBL] [Abstract][Full Text] [Related]
4. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study.
Montgomery E; Fisher C
Histopathology; 2001 Jun; 38(6):499-509. PubMed ID: 11422493
[TBL] [Abstract][Full Text] [Related]
5. Distribution of actin isoforms in sarcomas: an immunohistochemical study.
Roholl PJ; Elbers HR; Prinsen I; Claessens JA; van Unnik JA
Hum Pathol; 1990 Dec; 21(12):1269-74. PubMed ID: 2174404
[TBL] [Abstract][Full Text] [Related]
6. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
9. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.
Ueda T; Araki N; Mano M; Myoui A; Joyama S; Ishiguro S; Yamamura H; Takahashi K; Kudawara I; Yoshikawa H
J Clin Pathol; 2002 Nov; 55(11):853-8. PubMed ID: 12401825
[TBL] [Abstract][Full Text] [Related]
10. Expression of intermediate filaments in malignant fibrous histiocytomas.
Hirose T; Kudo E; Hasegawa T; Abe J; Hizawa K
Hum Pathol; 1989 Sep; 20(9):871-7. PubMed ID: 2550349
[TBL] [Abstract][Full Text] [Related]
11. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors.
Schürch W; Skalli O; Seemayer TA; Gabbiani G
Am J Pathol; 1987 Jul; 128(1):91-103. PubMed ID: 2440309
[TBL] [Abstract][Full Text] [Related]
12. Leiomyosarcomas: three cases with desmin positive tumour cells, lacking ultrastructural features of smooth muscle cells.
Roholl PJ; de Jong AS; Albus-Lutter CE; van Unnik JA
Histol Histopathol; 1988 Oct; 3(4):389-94. PubMed ID: 2980248
[TBL] [Abstract][Full Text] [Related]
13. Angiomatoid "malignant fibrous histiocytoma": an immunohistochemical study indicative of myoid differentiation.
Fletcher CD
Hum Pathol; 1991 Jun; 22(6):563-8. PubMed ID: 1650754
[TBL] [Abstract][Full Text] [Related]
14. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker.
Hisaoka M; Wei-Qi S; Jian W; Morio T; Hashimoto H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):302-8. PubMed ID: 11759055
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic leiomyosarcoma of the soft parts: a reassessment by histology and immunohistochemistry of pleomorphic soft tissue sarcomas.
Yamamoto I; Oshiro Y; Fukuda T; Tsuneyoshi M
Oncol Rep; 1999; 6(3):533-7. PubMed ID: 10203587
[TBL] [Abstract][Full Text] [Related]
16. h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors.
Watanabe K; Tajino T; Sekiguchi M; Suzuki T
Am J Clin Pathol; 2000 May; 113(5):663-8. PubMed ID: 10800398
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas.
Prieto VG; Reed JA; Shea CR
J Cutan Pathol; 1995 Aug; 22(4):336-41. PubMed ID: 7499573
[TBL] [Abstract][Full Text] [Related]
18. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
19. Malignant fibrous histiocytoma of the esophagus.
Naganuma H; Ohtani H; Sayama J; Sakai N; Taira Y; Shibuya D; Miyazaki A; Sakurada H
Pathol Int; 1996 Jun; 46(6):462-6. PubMed ID: 8869999
[TBL] [Abstract][Full Text] [Related]
20. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
